Sign In
Get Clay Free →

Suggestions

    Christopher Alvarez-Breckenridge

    Neurosurgeon

    Christopher Alvarez-Breckenridge is an Assistant Professor in the Department of Neurosurgery at The University of Texas MD Anderson Cancer Center.13 He is a surgeon-scientist who leads a highly collaborative, translational research group focusing on metastatic disease of the brain and spine.1

    Research Focus

    Dr. Alvarez-Breckenridge's research interests include:

    • Exploring unique tumor microenvironmental features of brain and spine metastases
    • Analyzing cellular composition and interactions in tumors
    • Investigating genetic, epigenetic, and transcriptional factors influencing tumor formation and treatment resistance
    • Developing animal models to study brain and spine metastasis formation
    • Exploring immunotherapeutic approaches, including oncolytic viral therapy

    Clinical Expertise

    His clinical expertise includes:

    • Spinal tumors
    • Metastatic disease involving the brain and spine45

    Education

    Dr. Alvarez-Breckenridge holds an MD/PhD from Ohio State University, which he completed in 2013.1

    Professional Activities

    As an Assistant Professor, he is actively involved in:

    • Leading a research group within the Department of Neurosurgery
    • Publishing peer-reviewed articles in scientific journals2
    • Collaborating with other researchers and clinicians
    • Exploring novel treatment approaches for patients through pre-clinical models and clinical trial implementation1

    Dr. Alvarez-Breckenridge's work combines his clinical practice with laboratory research, aiming to improve understanding and treatment of metastatic diseases affecting the brain and spine.

    Related Questions

    What are some of Christopher Alvarez-Breckenridge's most notable research contributions?
    How does Christopher Alvarez-Breckenridge's work on metastatic disease differ from other neurosurgeons?
    What are the main goals of Christopher Alvarez-Breckenridge's translational research group?
    Can you provide examples of Christopher Alvarez-Breckenridge's clinical trials?
    What specific immunotherapeutic approaches is Christopher Alvarez-Breckenridge exploring?